Medical Innovation Exchange

Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.